Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid van Tubergen

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Nature Reviews. Rheumatology|November 12, 2014
The changing clinical picture and epidemiology of spondyloarthritisAstrid van Tubergen
Best Practice & Research. Clinical Rheumatology|October 31, 2002
Spa and exercise treatment in ankylosing spondylitis: fact or fancy?Astrid van Tubergen, Alita Hidding
The Journal of Rheumatology|June 1, 2022
The Use of Mobile Health Apps in Clinical Practice Remains ChallengingAstrid van Tubergen, Kasper Hermans
Nature Reviews. Rheumatology|March 28, 2012
Diagnosis and classification in spondyloarthritis: identifying a chameleonAstrid van Tubergen, Ulrich Weber
Current Rheumatology Reports|June 12, 2015
Clinical Tools to Assess and Monitor SpondyloarthritisRobert Landewé, Astrid van Tubergen
Current Rheumatology Reports|September 24, 2009
Clinical assessment and outcome research in spondyloarthritisRobert B M Landewé, Astrid van Tubergen
Current Opinion in Rheumatology|April 18, 2023
Go or no-go for treat-to-target in axial spondyloarthritis?Casper Webers, Marin Been, Astrid van Tubergen
The Journal of Rheumatology|June 1, 2022
Are All Routine Spondyloarthritis Outpatient Visits Considered Useful by Rheumatologists? An Exploratory Clinical Practice StudyKasper Hermans, Annelies Boonen, Astrid van Tubergen
Nederlands Tijdschrift Voor Geneeskunde|March 12, 2024
[Biologicals in rheumatology: an overview of mechanisms of action and applications]Diane van der Woude, Astrid van Tubergen
RMD Open|June 1, 2023
Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritisEsther Beckers, Annelies Boonen, Astrid van Tubergen
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Nature Reviews. Rheumatology|November 12, 2014
The changing clinical picture and epidemiology of spondyloarthritisAstrid van Tubergen
Best Practice & Research. Clinical Rheumatology|October 31, 2002
Spa and exercise treatment in ankylosing spondylitis: fact or fancy?Astrid van Tubergen, Alita Hidding
The Journal of Rheumatology|June 1, 2022
The Use of Mobile Health Apps in Clinical Practice Remains ChallengingAstrid van Tubergen, Kasper Hermans
Nature Reviews. Rheumatology|March 28, 2012
Diagnosis and classification in spondyloarthritis: identifying a chameleonAstrid van Tubergen, Ulrich Weber
Current Rheumatology Reports|June 12, 2015
Clinical Tools to Assess and Monitor SpondyloarthritisRobert Landewé, Astrid van Tubergen
Current Rheumatology Reports|September 24, 2009
Clinical assessment and outcome research in spondyloarthritisRobert B M Landewé, Astrid van Tubergen
Current Opinion in Rheumatology|April 18, 2023
Go or no-go for treat-to-target in axial spondyloarthritis?Casper Webers, Marin Been, Astrid van Tubergen
The Journal of Rheumatology|June 1, 2022
Are All Routine Spondyloarthritis Outpatient Visits Considered Useful by Rheumatologists? An Exploratory Clinical Practice StudyKasper Hermans, Annelies Boonen, Astrid van Tubergen
Nederlands Tijdschrift Voor Geneeskunde|March 12, 2024
[Biologicals in rheumatology: an overview of mechanisms of action and applications]Diane van der Woude, Astrid van Tubergen
RMD Open|June 1, 2023
Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritisEsther Beckers, Annelies Boonen, Astrid van Tubergen
Pageof 13